Design and pharmacokinetical aspects for the use of inorganic nanoparticles in radiomedicine
V Puntes - The British journal of radiology, 2016 - academic.oup.com
The potential use of nanoparticles (NPs) in medicine is determined by the pharmacokinetical
and biodistribution aspects that govern NP behaviour. In this context, diagnosis (low …
and biodistribution aspects that govern NP behaviour. In this context, diagnosis (low …
Design and pharmacokinetical aspects for the use of inorganic nanoparticles in radiomedicine
V Puntes - The British journal of radiology, 2016 - pubmed.ncbi.nlm.nih.gov
The potential use of nanoparticles (NPs) in medicine is determined by the pharmacokinetical
and biodistribution aspects that govern NP behaviour. In this context, diagnosis (low …
and biodistribution aspects that govern NP behaviour. In this context, diagnosis (low …
Design and pharmacokinetical aspects for the use of inorganic nanoparticles in radiomedicine.
V Puntes - The British Journal of Radiology, 2015 - europepmc.org
The potential use of nanoparticles (NPs) in medicine is determined by the pharmacokinetical
and biodistribution aspects that govern NP behaviour. In this context, diagnosis (low …
and biodistribution aspects that govern NP behaviour. In this context, diagnosis (low …
[HTML][HTML] Design and pharmacokinetical aspects for the use of inorganic nanoparticles in radiomedicine
V Puntes - The British Journal of Radiology, 2016 - ncbi.nlm.nih.gov
The potential use of nanoparticles (NPs) in medicine is determined by the pharmacokinetical
and biodistribution aspects that govern NP behaviour. In this context, diagnosis (low …
and biodistribution aspects that govern NP behaviour. In this context, diagnosis (low …